Cargando…
Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel
BACKGROUND: Low density lipoprotein (LDL) has been regarded as a promising antitumor drug vehicle. However some problems, such as rare source, difficulty of large-scale production, and potential safety concerns, hinder its clinical application. PURPOSE: The objective of this study is to develop a bi...
Autores principales: | Qian, Junyi, Xu, Ningze, Zhou, Xu, Shi, Kaihong, Du, Qian, Yin, Xiaoxing, Zhao, Ziming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751769/ https://www.ncbi.nlm.nih.gov/pubmed/31686815 http://dx.doi.org/10.2147/IJN.S215080 |
Ejemplares similares
-
Amphipathic Peptides Impede Lipid Domain Fusion in Phase-Separated Membranes
por: Pinigin, Konstantin V., et al.
Publicado: (2021) -
A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles
por: Sarkar, Samantha K., et al.
Publicado: (2020) -
Flexibility vs rigidity of amphipathic peptide conjugates when interacting with lipid bilayers
por: Babii, Oleg, et al.
Publicado: (2017) -
The Membrane-Mediated Interaction of Liquid-Ordered Lipid Domains in the Presence of Amphipathic Peptides
por: Pinigin, Konstantin V., et al.
Publicado: (2023) -
Cationic amphipathic peptides accumulate sialylated proteins and lipids in the plasma membrane of eukaryotic host cells
por: Weghuber, Julian, et al.
Publicado: (2011)